Results 211 to 220 of about 54,905 (262)

Discovery of a Novel Selective Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist for the Treatment of Primary Biliary Cirrhosis. [PDF]

open access: yesACS Med Chem Lett, 2019
Jiang Z   +18 more
europepmc   +1 more source

Bone mass in women with primary biliary cirrhosis: The relation with histological stage and use of glucocorticoids

open access: bronze, 1990
F.N.R. Van Berkum   +5 more
openalex   +1 more source

Initial Clinical Experience With the Oral Cholate Challenge Test: Results From the 2023–2024 Early Access Program

open access: yesLiver International Communications, Volume 6, Issue 4, December 2025.
ABSTRACT The oral cholate challenge test of liver health, intended for use in compensated advanced chronic liver disease, was launched through an Early Access Program (EAP) in 2023–2024. Tests were provided to 16 clinicians at five liver centres across the US. The tested patients (n = 129) represented a range of etiologies and stages of disease.
Stuart C. Gordon   +3 more
wiley   +1 more source

A case of primary biliary cirrhosis(PBC) associated with acute autoimmune hepatitis(AIH).

open access: diamond, 1992
Ryoichi Ishihata   +11 more
openalex   +2 more sources

Ovarian Aging: Mechanisms, Age‐Related Disorders, and Therapeutic Interventions

open access: yesMedComm, Volume 6, Issue 12, December 2025.
A comprehensive overview of the molecular mechanisms underlying ovarian aging, its association with age‐related diseases, and potential therapeutic interventions. Ovarian aging involves DNA damage, mitochondrial dysfunction, oxidative stress, telomere attrition, and follicular depletion, driving age‐related infertility, menopause, and multiple systemic
Xingyu Liu   +4 more
wiley   +1 more source

Xanthoma Striatum Palmare in a Patient of Primary Biliary Cirrhosis with Autoimmune Hepatitis. [PDF]

open access: yesAnn Dermatol, 2017
Yang MY   +6 more
europepmc   +1 more source

High‐Throughput Screening Using the Self‐Controlled Tree‐Based Scan Statistic to Identify Medications Associated With Hospitalization for Severe Acute Liver Injury

open access: yesPharmacoepidemiology and Drug Safety, Volume 34, Issue 12, December 2025.
ABSTRACT Background Medications associated with acute liver injury (ALI) are primarily identified by case reports. High‐throughput screening of real‐world data could be leveraged to detect hepatotoxicity signals. Objective To apply tree‐based scan statistics in real‐world data to identify drugs associated with hospitalization for severe ALI among ...
Vincent Lo Re III   +5 more
wiley   +1 more source

Tubulointerstitial nephritis associated with primary biliary cirrhosis [PDF]

open access: yesJournal of Nephropharmacology, 2014
Rasolzadegan Mohammad-Hosein   +2 more
doaj  

Pulmonary Manifestations among Patients with Primary Biliary Cirrhosis. [PDF]

open access: yesJ Clin Transl Hepatol, 2016
Koksal D, Koksal AS, Gurakar A.
europepmc   +1 more source

Home - About - Disclaimer - Privacy